The Impact of FDA Reviewers on Drug Approval Decisions
When it comes to FDA drug approval decisions, the expertise of individual reviewers is crucial. However, a recent case revealed that the review team did not have a say in the vote for the first product from a company that received a priority voucher. Instead, top agency leaders took charge of the voting process, sparking concerns about political influences. Bioethics and law professor Holly Fernandez Lynch highlighted the potential implications of having commissioners involved in such decisions. To learn more about this issue and the role of reviewers in the process, check out the full report by STAT’s Lizzy Lawrence.
Challenges in Accessing Opioid Use Disorder Treatment
A recent study published in The American Journal of Drug and Alcohol Abuse shed light on the struggles faced by Medicaid enrollees with opioid use disorder. The research revealed that 7 in 10 individuals do not receive treatment within six months of diagnosis, with a small percentage experiencing overdose episodes. The study emphasized the importance of medications like methadone and buprenorphine in reducing the risk of overdose. However, with impending Medicaid cuts, there are concerns about the accessibility of these life-saving treatments. For more insights into this issue, delve into Lev Facher’s War on Recovery series.
The Evolution of Hemp Legislation and Its Impact
In 2018, Congress passed laws legalizing hemp products within specific THC concentrations. However, a recent provision in the spending bill aims to restrict intoxicating THC products, potentially reverting marijuana’s legal status. This change could disrupt access to essential products for many Americans. Lev Facher explores the implications of this legislation and its timeline for implementation in his detailed analysis.
Preserving the Vital Role of Healthy Start Programs
The Healthy Start program has been instrumental in supporting families during and after pregnancy, providing crucial services like breastfeeding education and access to healthcare. However, the program faces funding challenges, with recent proposals to eliminate its funding. STAT’s Eric Boodman delves into the impact of these potential cuts through the lens of Healthy Start case manager Malaika Milele Gardner and her client Erica Williams. Their story showcases the invaluable support provided by these programs, emphasizing the need to safeguard their funding.
Remembering a Scientific Leader at CDC
The recent passing of Walter Dowdle, a prominent scientific leader at the CDC, has sparked reflections on his remarkable contributions to public health. Dowdle’s tenure at the CDC was marked by his exceptional scientific acumen and leadership, earning him accolades from colleagues and peers. Former CDC director William Foege praised Dowdle’s multifaceted talents and his lasting impact on the field of infectious diseases. A celebration of his life is scheduled for December 12, honoring his legacy in public health.
Navigating Challenges in the Neurodiversity Movement
Jack Pemment, an advocate for the neurodiversity movement, raises concerns about the movement’s vulnerability to attacks due to vague definitions and language. Pemment, who is autistic himself, underscores the need for credible responses to preserve the momentum of the movement. By addressing these challenges head-on, advocates can ensure the continued progress of the neurodiversity movement. Explore Pemment’s insights on navigating these challenges and safeguarding the movement’s objectives.
Further Reading and Insights
- U.S. cancer registries to recognize only ‘male’ or ‘female’ patients, KFF Health News
- A battle with my blood, New Yorker
- Is Slingshot’s mental health chatbot safe? Its first study raises questions about evaluating AI, STAT
- Lessons from a European country’s struggle with measles, NPR
- CDC moves to end telework for employees, including those with medical needs, STAT
